28040133|t|Molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome derived from chromosome 8 or r(8)(::p11.22→q11.21::) in an 18- year-old female with short stature, obesity, attention deficit hyperactivity disorder, and intellectual disability
28040133|a|We present molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome (sSMC) derived from chromosome 8. An 18- year-old female presented with short stature, obesity, developmental delay, speech delay, dyslexia, attention deficit hyperactivity disorder, and intellectual disability. Cytogenetic analysis of the peripheral blood revealed a karyotype of 47,XX,+mar[22]/46,XX[18]. Array comparative genomic hybridization and metaphase fluorescence in situ hybridization analyses were performed on the peripheral blood to determine the origin and mosaicism of the sSMC, and quantitative fluorescent polymerase chain reaction was used to exclude uniparental disomy. Array comparative genomic hybridization analysis of the blood revealed a result of arr 8p11.22q11.21 (39,136,065-49,725,726)×2.80 (Log2 ratio =0.49), consistent with 70-80% mosaicism, encompassing 33 OMIM genes including GOLGA7, AGPAT6, NKX6-3, KAT6A, and FNTA. The sSMC(8) was r(8)(::p11.22→q11.21::). Metaphase fluorescence in situ hybridization analysis using the probes of RP11-754D24 (8p11.21) and RP11-769N21 (8q11.21) showed the sSMC(8) in 12/27 of cultured lymphocytes. Quantitative fluorescent polymerase chain reaction analysis excluded uniparental disomy 8. Mosaic sSMC(8) derived from r(8)(::p11.22→q11.21::) can be associated with obesity, intellectual disability, and attention deficit hyperactivity disorder.
28040133	0	38	Molecular cytogenetic characterization	T052	C1880022
28040133	42	51	mosaicism	T032	C0026578
28040133	58	95	small supernumerary marker chromosome	T026	C0008633
28040133	109	121	chromosome 8	T026	C0008671
28040133	125	148	r(8)(::p11.22→q11.21::)	T026	C0008671
28040133	159	167	year-old	T079	C1510829
28040133	168	174	female	T098	C0043210
28040133	180	193	short stature	T033	C0349588
28040133	195	202	obesity	T047	C0028754
28040133	204	244	attention deficit hyperactivity disorder	T048	C1263846
28040133	250	273	intellectual disability	T048	C3714756
28040133	285	323	molecular cytogenetic characterization	T052	C1880022
28040133	327	336	mosaicism	T032	C0026578
28040133	343	380	small supernumerary marker chromosome	T026	C0008633
28040133	382	386	sSMC	T026	C0008633
28040133	401	413	chromosome 8	T026	C0008671
28040133	422	430	year-old	T079	C1510829
28040133	431	437	female	T098	C0043210
28040133	453	466	short stature	T033	C0349588
28040133	468	475	obesity	T047	C0028754
28040133	477	496	developmental delay	T048	C0424605
28040133	498	510	speech delay	T048	C0241210
28040133	512	520	dyslexia	T048	C0476254
28040133	522	562	attention deficit hyperactivity disorder	T048	C1263846
28040133	568	591	intellectual disability	T048	C3714756
28040133	593	613	Cytogenetic analysis	T063	C0752095
28040133	621	637	peripheral blood	T031	C0229664
28040133	649	686	karyotype of 47,XX,+mar[22]/46,XX[18]	T059	C1261273
28040133	688	727	Array comparative genomic hybridization	T063	C2931151
28040133	732	785	metaphase fluorescence in situ hybridization analyses	T063	C0162789
28040133	808	824	peripheral blood	T031	C0229664
28040133	842	848	origin	T079	C0439659
28040133	853	862	mosaicism	T032	C0026578
28040133	870	874	sSMC	T026	C0008633
28040133	880	930	quantitative fluorescent polymerase chain reaction	T059	C2733320
28040133	951	969	uniparental disomy	T049	C0949628
28040133	971	1019	Array comparative genomic hybridization analysis	T063	C2931151
28040133	1027	1032	blood	T031	C0005767
28040133	1044	1050	result	T169	C1274040
28040133	1102	1112	Log2 ratio	T081	C0392762
28040133	1121	1136	consistent with	T078	C0332290
28040133	1144	1153	mosaicism	T032	C0026578
28040133	1171	1181	OMIM genes	T028	C0017337
28040133	1192	1198	GOLGA7	T028	C1428422
28040133	1200	1206	AGPAT6	T028	C1826612
28040133	1208	1214	NKX6-3	T028	C1826430
28040133	1216	1221	KAT6A	T028	C1421709
28040133	1227	1231	FNTA	T028	C1414655
28040133	1237	1244	sSMC(8)	T026	C0008671
28040133	1249	1272	r(8)(::p11.22→q11.21::)	T026	C0008671
28040133	1274	1327	Metaphase fluorescence in situ hybridization analysis	T063	C0162789
28040133	1338	1344	probes	T114,T130	C0008599
28040133	1348	1359	RP11-754D24	T026	C1521695
28040133	1361	1368	8p11.21	T026	C1521695
28040133	1374	1385	RP11-769N21	T026	C0243092
28040133	1387	1394	8q11.21	T026	C0243092
28040133	1407	1414	sSMC(8)	T026	C0008671
28040133	1427	1447	cultured lymphocytes	T025	C0024264
28040133	1449	1508	Quantitative fluorescent polymerase chain reaction analysis	T059	C2733320
28040133	1518	1538	uniparental disomy 8	T049	C2931670
28040133	1540	1554	Mosaic sSMC(8)	T026	C0008671
28040133	1568	1591	r(8)(::p11.22→q11.21::)	T026	C0008671
28040133	1599	1614	associated with	T080	C0332281
28040133	1615	1622	obesity	T047	C0028754
28040133	1624	1647	intellectual disability	T048	C3714756
28040133	1653	1693	attention deficit hyperactivity disorder	T048	C1263846